sumatriptan
Drug Details
- Generic Name
- sumatriptan
- Brand Names
- SUMATRIPTAN, IMITREX, sumatriptan, TOSYMRA, Sumatriptan
- Application Number
- ANDA200183
- Sponsor
- GlaxoSmithKline LLC
- NDC Codes
- 30
- Dosage Forms
- TABLET, FILM COATED, INJECTION, SPRAY, INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS, NASAL, ORAL
- Active Ingredients
- SUMATRIPTAN SUCCINATE, SUMATRIPTAN
Indications and Usage
1 INDICATIONS AND USAGE Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: • Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with sumatriptan, reconsider the diagnosis of migraine before sumatriptan is administered to treat any subsequent attacks. • Sumatriptan is not indicated for the prevention of migraine attacks. • Safety and effectiveness of sumatriptan tablets have not been established for cluster headache. Sumatriptan is a serotonin (5-HT1B/1D) receptor agonist (triptan) indicated for acute treatment of migraine with or without aura in adults. Limitations of Use: • Use only if a clear diagnosis of migraine headache has been established. (1) • Not indicated for the prophylactic therapy of migraine attacks. (1) • Not indicated for the treatment of cluster headache. (1)